AKT1 and Cognitive impairment: This finding also raises the possibility that Rg1 and Rb1 treatment may affect BDNF-PI3K/Akt signaling in the PFC, which controls the expression of SYN and PSD95 and thus synaptic plasticity, thus reducing cognitive deficits in the rats.